Monitoring the quality of lifesaving medicines is Novilytics mission. We accomplish this via the disruptive use of nanotechnology and cutting-edge science designed for Process R&D and pharmaceutical manufacturing. The Proteometer (Proteoform Meter) is a technology for drug development companies that can provide near-real-time warnings on molecular structure changes. Like a canary in an old coal mine, the Proteometer serves as our Canary in the Fermentor. This technology is sold in the form of kits that allow customers to convert their LCs into a Proteometer in a short period of time. Training and service all remain the same, including ones own software, thus ensuring ease of use and speed of adoption. The Proteometer launched in February of 2023, with the organization preparing for more innovative product launches in the next year.